Making Decisions About the Measles-Mumps-Rubella Vaccine

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by University of Michigan.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Amanda Dempsey, University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01369394
First received: June 7, 2011
Last updated: February 10, 2012
Last verified: February 2012
  Purpose

The goal of this study is to determine whether a computer-based intervention that delivers individually-tailored educational messages about the MMR vaccine increases MMR vaccine-hesitant parents' intentions to have their children vaccinated.


Condition Intervention
Measles
Mumps
Rubella
MMR Vaccination
Other: Behavioral: Computer-based tailoring system

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: Developing a Computer-based Intervention That Provides Individually-tailored Educational Information for MMR Vaccine-hesitant Parents

Resource links provided by NLM:


Further study details as provided by University of Michigan:

Primary Outcome Measures:
  • Parent's intention to vaccinate child against MMR [ Time Frame: Date of intervention (one day) ] [ Designated as safety issue: No ]
    Parent will rate his/her intention to have child vaccinated against MMR using a Likert scale before and after the intervention.


Secondary Outcome Measures:
  • Use of the intervention [ Time Frame: At the time of intervention participation ] [ Designated as safety issue: No ]
    We will assess the number of pages viewed and time spend per page for each participant viewing the intervention.


Enrollment: 79
Study Start Date: June 2011
Estimated Study Completion Date: July 2012
Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Tailored information
Individuals assigned to the experimental group will receive individually-tailored educational messages.
Other: Behavioral: Computer-based tailoring system
Both the intervention and control groups will use a computer-based tailoring system to respond to survey questions. The computer-based tailoring system will generate educational messages based on participants' responses to survey questions. The intervention group will receive tailored educational messages, whereas the control group will receive generic educational messages. The tailored and generic educational messages will be presented as to look like web pages. However, the messages will only exist on the study computer, and will not be linked to any "live" server or website.
Active Comparator: Untailored information
Individuals assigned to the control group will receive generic, untailored educational messages.
Other: Behavioral: Computer-based tailoring system
Both the intervention and control groups will use a computer-based tailoring system to respond to survey questions. The computer-based tailoring system will generate educational messages based on participants' responses to survey questions. The intervention group will receive tailored educational messages, whereas the control group will receive generic educational messages. The tailored and generic educational messages will be presented as to look like web pages. However, the messages will only exist on the study computer, and will not be linked to any "live" server or website.

Detailed Description:

This will be a randomized controlled intervention trial for MMR vaccine-hesitant parents of children ages six years and younger who have not yet received the MMR vaccine. Parents will complete a three-item measure that assesses their baseline intentions for having their children vaccinated with MMR. Participants will then fill out a short, computer-based survey that assesses demographic factors, prior experience with MMR, and views about a variety of potential barriers to MMR vaccination. Following the survey, the intervention group (40 parents) will view a series of tailored educational messages resembling web pages that uses their survey data to address at an individual level their specific concerns about the MMR vaccine. The control group (40 parents) will view a series of generic educational messages resembling web pages that is similar in appearance to the intervention, but contains only untailored information about the vaccine. After navigating through these educational messages, MMR vaccination intention will be reassessed using the same three-item measure as for the baseline assessment of vaccination intention. The vaccine administration records of the children of these parents will be accessed after parents' participation in the study to assess whether the MMR vaccine was provided to the child.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Parent is greater than or equal to 18 years of age
  • Parent has a child 6 years of age or younger
  • When asked to describe how he/she feels about getting child vaccinated against MMR, parent responds "I don't want to get my child vaccinated" or "I'm unsure if I want my child to get vaccinated"

Exclusion Criteria:

  • Cannot read/speak English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01369394

Locations
United States, Michigan
UMHS Outpatient Pediatrics
Ann Arbor, Michigan, United States, 48109
Sponsors and Collaborators
University of Michigan
Investigators
Principal Investigator: Amanda Dempsey, MD, PhD, MPH Children's Outcomes Research Program
  More Information

No publications provided

Responsible Party: Amanda Dempsey, Associate Professor of Pediatrics, University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT01369394     History of Changes
Other Study ID Numbers: 186564
Study First Received: June 7, 2011
Last Updated: February 10, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Michigan:
Measles
Mumps
Rubella
MMR
Prevention
Tailoring
Persuasive communication
Children

Additional relevant MeSH terms:
Measles
Mumps
Rubella
Mononegavirales Infections
Morbillivirus Infections
Mouth Diseases
Paramyxoviridae Infections
Parotid Diseases
Parotitis
RNA Virus Infections
Rubivirus Infections
Rubulavirus Infections
Salivary Gland Diseases
Stomatognathic Diseases
Togaviridae Infections
Virus Diseases

ClinicalTrials.gov processed this record on October 23, 2014